Peer-reviewed, open access journal

Menu
  • About Cancer Immunology & Translational Research

Cancer Immunology & Translational Research is established as a dedicated scholarly platform for research examining how immune mechanisms influence cancer development, progression, therapeutic response, and clinical outcomes.

The journal brings together complementary areas of cancer research that are often studied independently. By providing a common forum for immunologists, oncologists, molecular researchers, translational scientists, computational investigators, and clinical researchers, CITR seeks to facilitate meaningful exchange across the cancer research continuum.

The journal considers research ranging from fundamental discoveries in tumor–immune biology to translational investigations and clinically oriented studies.

Our Mission

To facilitate the rigorous communication of research that advances understanding of cancer immunology and contributes to the development of scientifically grounded approaches for cancer prevention, diagnosis, prognosis, treatment, and patient management.

Our Vision

To foster an interdisciplinary research community in which discoveries in cancer immunology can be evaluated, developed, and translated toward meaningful advances in cancer science and medicine.

Editorial Perspective

CITR recognizes that translational progress does not follow a single pathway. Fundamental discoveries may provide the basis for future therapeutic development, while clinical observations may generate new biological questions.

  • The journal therefore supports a continuum of research:

Discovery → Validation → Translation → Application